Gain Therapeutics (GANX) Receivables - Other (2021 - 2025)
Historic Receivables - Other for Gain Therapeutics (GANX) over the last 5 years, with Q3 2025 value amounting to $517094.0.
- Gain Therapeutics' Receivables - Other changed N/A to $517094.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $517094.0, marking a year-over-year change of. This contributed to the annual value of $494684.0 for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Gain Therapeutics' Receivables - Other is $517094.0.
- Gain Therapeutics' 5-year Receivables - Other high stood at $1.1 million for Q2 2025, and its period low was $33261.0 during Q1 2023.
- For the 5-year period, Gain Therapeutics' Receivables - Other averaged around $324244.7, with its median value being $98954.5 (2022).
- Per our database at Business Quant, Gain Therapeutics' Receivables - Other soared by 680.17% in 2022 and then crashed by 6493.79% in 2023.
- Quarter analysis of 5 years shows Gain Therapeutics' Receivables - Other stood at $81862.0 in 2021, then increased by 6.8% to $87430.0 in 2022, then crashed by 61.96% to $33261.0 in 2023, then soared by 1387.28% to $494684.0 in 2024, then rose by 4.53% to $517094.0 in 2025.
- Its Receivables - Other stands at $517094.0 for Q3 2025, versus $1.1 million for Q2 2025 and $638961.0 for Q1 2025.